As reported in the legal brief (b)(6) vs.Cordis, approximately 3 months after an optease ivc filter was implanted, the plaintiff was found to have developed occlusive thrombus extending from bilateral common femoral veins through both calves believed to be attributable to the cordis optease ivc filter.Additional information was also received that the filter subsequently malfunctioned and caused injury and damages to including, but not limited to, fracture of the ivc filter, caval thrombosis, dvt, and post-thrombotic syndrome.As a direct and proximate result of these malfunctions, plaintiff suffered life-threatening injuries and damages, and required extensive medical care and treatment.
|
As reported in the legal brief, approximately 3 months after an optease ivc filter was implanted, the plaintiff was found to have developed occlusive thrombus extending from bilateral common femoral veins through both calves believed to be attributable to the cordis optease ivc filter.Additional information was also received that the filter subsequently malfunctioned and caused injury and damages to including, but not limited to, fracture of the ivc filter, caval thrombosis, dvt, and post-thrombotic syndrome.As a direct and proximate result of these malfunctions, plaintiff suffered life-threatening injuries and damages, and required extensive medical care and treatment.The product was not returned for analysis.Additionally, as the sterile lot number was not available, device history record review could not be performed.The optease filter is indicated for use in the prevention of recurrent pulmonary embolism (pe) via percutaneous placement in the vena cava for patients in which anticoagulants are contraindicated, anticoagulant therapy for thromboembolic disease has failed, emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced or for chronic, recurrent pulmonary embolism where anticoagulant therapy has failed, or is contraindicated.The purpose of a vena cava filter is to catch thrombus from the lower extremities as it travels along normal blood flow patterns up towards the heart.Vena cava thrombus and deep vein thrombus within the legs does not represent a device malfunction.Factors that may have influenced the event include patient, pharmacological and lesion characteristics.Without procedural films for review, the reported filter fracture could not be confirmed and the exact cause could not be determined.The instructions for use (ifu) states filter fracture is a potential complication of vena cava filters.Anatomic locations that create concentrated stress points from filter deformation (for example, deployment at apex of scoliosis, overlapping of either of the renal ostia, or placement adjacent to a vertebral osteophyte) may contribute to fracture of a particular filter strut.Given the limited information available for review at this time, there is nothing to suggest that the reported event is related to the design and manufacturing process of the device; therefore no corrective action will be taken.Should additional information become available, the file will be updated accordingly.
|